Based on the Oncomine database records, the expression of Zn-exporter genes SLC30A1, SLC30A9, and SLC30A10 are upregulated, and SLC30A5 and SLC30A6 are downregulated in prostate cancer compared to BPH [90]. This evidence concerns the gene SLC30A9 and benign prostatic hyperplasia.